Hepatitis C virus prevalence and genotype distribution in Pakistan: Comprehensive review of recent data

Table 2 Seroprevalence of hepatitis C virus infection in blood donors

S. #	Year	Place	Method	Sample size	Seroprevalence (%)	Ref.
1	2009	Mirpurkhas	ELISA7	804	15.05	[25]
2	2010	Multan	ELISA1	10000	4.90	[88]
3	2010	Peshawar	ELISA7	32042	1.57	[92]
4	2011	KPK/FATA	ELISA2	7148	1.89	[89]
5	2011	KPK/FATA	ELISA2	62251	2.60	[91]
6	2011	Karachi	-8	5717	1.90	[86]
7	2012	Karachi	ELISA3	5517	2.00	[83]
8	2012	Peshawar	ELISA2	127828	2.46	[84]
9	2012	Sargodha	ELISA3	100	12.00	[85]
10	2013	Karachi	MEIA/CLIA4	108598	2.61	[87]
11	2013	Quetta	ELISA2	356	20.8	[27]
12	2013	Lahore	ELISA5	245	15.00	[82]
13	2014	Karachi	CLIA6	42830	1.65	[90]

¹Labkit Chemelex, Barcelona, Spain;

²Biokit;

³General Biologicals Corporation, Taiwan;

⁴Abbott Diagnostics,

⁵DiaSorin;

⁶Ortho Clinical Diagnostics, NJ, United States;

⁷Manufacturer not mentioned in cited reference;

⁸Method not mentioned in cited reference. KPK: Khyber Pakhtunkhwa; FATA: Federally Administered Tribal Areas; ELISA: Enzyme linked immunosorbent assay; MEIA: Microparticle immunoassay; CLIA: Chemiluminescence immunoassay.